Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision loss from diabetes
More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of ...
With $66 million R&D center, Boehringer Ingelheim fulfills economic development pledge to state
The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...
FiercePharma11d
In FDA adcomm, Lexicon gets another thumbs down for type 1 diabetes hopeful Zynquista
On Halloween, Lexicon was haunted again as an FDA advisory committee voted 11-3 to reject Zynquista as an accompanying ...
Na Presseportal19d
POL-VDMZ: Probefahrt mit Folgen
Ingelheim (ots) - Am 26.10.2024 kam es gegen 14:50 Uhr zu einem Diebstahl in der Goldschmiede Zwehn in der Binger Straße in Ingelheim am Rhein. Hierbei erbeutete der männliche Täter mehrere ...
Anwalt22d
Arbeitsrecht • Allgemeines Vertragsrecht • Zivilrecht • Verwaltungsrecht • Steuerrecht • Insolvenzrecht & Sanierungsrecht • Beamtenrecht
aus 29 Bewertungen Der Herr Eschborn ist als Anwalt sehr Kompetent, Vertrauenswürdig ,freundlich im Kontakt, hat mir sehr bei meiner … (22.10.2024) ...
FierceBiotech29d
Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug
Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...
Financial Post29d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...
Pharmaceutical Technology29d
Boehringer partners WHO Foundation to advance healthcare access
Boehringer Ingelheim partners with the WHO Foundation to financially support WHO’s Fourteenth General Programme of Work (2025 to 2028). Credit: PeopleImages.com – Yuri A/Shutterstock. Boehringer ...
Business Wire1mon
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment
INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal ...